- Home
- UBER vs PFE Comparison
UBER vs PFE Comparison
Compare UBER & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UBER | PFE |
|---|---|---|
| Founded | 2009 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.1B | 161.2B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | UBER | PFE |
|---|---|---|
| Price | $69.29 | $28.82 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 50 | 28 |
| Target Price | ★ $98.88 | $30.22 |
| AVG Volume (30 Days) | 15.4M | ★ 23.7M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 5.97% |
| EPS Growth | ★ 3.73 | N/A |
| EPS | ★ 1.54 | 0.99 |
| Revenue | $52,017,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $11.06 | $0.88 |
| Revenue Next Year | $15.84 | N/A |
| P/E Ratio | $44.96 | ★ $29.21 |
| Revenue Growth | ★ 18.28 | N/A |
| 52 Week Low | $64.04 | $23.62 |
| 52 Week High | $92.92 | $31.44 |
Technical Indicators
Market Signals| Indicator | UBER | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 44.46 |
| Support Level | $66.14 | $26.68 |
| Resistance Level | $72.29 | $28.94 |
| Average True Range (ATR) | 2.02 | 0.72 |
| MACD | 0.43 | -0.21 |
| Stochastic Oscillator | 63.12 | 9.48 |
Price Performance
Historical ComparisonAbout UBER Uber Technologies Inc.
Uber is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars and autonomous vehicles, but could eventually support additional products and services, such as drone delivery or electric vertical takeoff and landing (eVTOL) technology. Uber operates in over 70 countries and has over 200 million users who order rides or food at least once a month.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.